Morgan Stanley Maintains Equal-Weight on IQVIA Holdings, Raises Price Target to $270

9/17/2026
Impact: 70
Healthcare

Morgan Stanley analyst Kallum Titchmarsh has maintained an Equal-Weight rating on IQVIA Holdings (NYSE: IQV) while raising the price target from $240 to $270. This adjustment reflects a positive outlook on the company's performance.

AI summary, not financial advice

Share: